Cardiac Rehabilitation Market Size and Share
Cardiac Rehabilitation Market Analysis by Mordor Intelligence
The cardiac rehabilitation equipment market size stood at USD2.45billion in2025 and is forecast to reach USD3.28 billion by2030, reflecting a 6.0% CAGR. Rising adoption of AI-enabled feedback systems, virtual-reality exercise stations, and remote telemetry platforms is redefining care pathways and supporting consistent growth in the cardiac rehabilitation equipment market. Connected treadmills and cycle-ergometers now feature cloud integrations that allow clinicians to adjust prescriptions in real time, while pneumatic strength machines are expanding participation among frail and elderly patients. Home-based programs are accelerating as reimbursers approve hybrid models, underscoring sustained momentum for the cardiac rehabilitation equipment market across clinical and residential settings. Consolidation continues, with acquisitions such as ScottCare joining Marmon Holdings and partnerships like HeartBeam–AccurKardia strengthening product portfolios.
Key Report Takeaways
•By product type, aerobic training equipment led with 34.45% revenue share in2024, whereas emerging technologies are projected to expand at a6.27% CAGR to2030.
•By portability, fixed equipment held71.29% of the cardiac rehabilitation equipment market share in2024, while portable solutions are advancing at a7.23% CAGR.
•By end user, hospitals captured47.87% share of the cardiac rehabilitation equipment market size in2024, and home settings are forecast to grow at a7.56% CAGR through2030.
•By geography, North America accounted for39.50% revenue share in2024; Asia Pacific is the fastest-growing region at a6.71% CAGR
Global Cardiac Rehabilitation Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Growing installation of connected treadmills & cycle-ergometers in CR labs | +1.2% | Global, with early adoption in North America & EU | Medium term (2-4 years) |
| Integration of wearable sensors & remote telemetry into rehab devices | +1.5% | Global, accelerated in APAC markets | Short term (≤ 2 years) |
| Shift to low-impact pneumatic strength machines for frail patients | +0.8% | North America & EU core, expansion to APAC | Long term (≥ 4 years) |
| AI-enabled feedback loops boosting utilisation of home-use devices | +1.3% | Global, with premium adoption in developed markets | Medium term (2-4 years) |
| Virtual-reality rehab stations creating a new product niche | +0.7% | North America & EU initial, selective APAC rollout | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Growing installation of connected treadmills& cycle-ergometers in CR labs
Real-time data capture has reshaped supervision as cloud-linked ergometers stream heart-rate, wattage, and cadence to clinician dashboards. Teams adjust workloads instantly, turning each session into a data-driven experiment that fits diverse comorbidity profiles. Automated uploads satisfy accreditation metrics, trimming paperwork and freeing staff for coaching. Gamified progress bars boost motivation, and facilities report 15% higher adherence than programs that use standalone machines. Together, these benefits position connected aerobic devices as the new standard for cardiac rehabilitation laboratories.
Integration of wearable sensors& remote telemetry into rehab devices
Continuous ECG, blood-pressure, and pulse-ox feeds now merge with equipment telemetry, giving clinicians second-by-second insight into physiologic response. Real-time analytics flag arrhythmias or unsafe pressures and can pause sessions automatically, improving safety for high-risk cohorts. Remote dashboards extend oversight to home programs, easing staffing shortages while sustaining clinical rigor. Facilities that embed telemetry report 23% lower dropout and faster attainment of goal workloads. The approach underpins scalable hybrids that blend clinic initiation with remote progression.
Shift to low-impact pneumatic strength machines for frail patients
Pneumatic resistance regulates load with compressed air, creating smooth curves that spare joints and surgical sites. This capability is vital for frail or elderly patients who face injury risk with free weights or stacks. Trials show comparable strength gains to conventional gear while cutting joint stress by 40%. Smaller footprints let facilities add more stations in tight spaces, raising throughput in urban centers. As reimbursement shifts toward functional outcomes, demand for low-impact platforms is set to accelerate
AI-enabled feedback loops boosting utilisation of home-use devices
Home-use bikes and steppers now ship with chips that ingest heart-rate, torque, and self-reported symptoms. Embedded AI adjusts resistance or cadence on the fly so patients stay within prescribed intensity zones. Alerts reach clinicians if biometrics drift outside safe ranges, enabling intervention without extra visits. Personalisation raises completion rates to 87% versus 54% for static protocols. Such results push payers toward permanent coverage for tech-enabled home rehabilitation.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High capital & maintenance costs for hospitals and centres | -1.80% | Global, acute in developing markets | Short term (≤ 2 years) |
| Space constraints limit deployment of large equipment | -0.90% | Urban markets globally, severe in APAC | Medium term (2-4 years) |
| Shortage of biomedical engineers for device upkeep | -1.10% | Global, critical in rural and emerging markets | Long term (≥ 4 years) |
| Lack of harmonised MDR/510(k) pathways for digital features | -0.70% | Global, regulatory fragmentation in EU-US-APAC | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
High capital & maintenance costs for hospitals and centres
Up-front prices for advanced treadmills, telemetry consoles, and exoskeletons can reach USD 50,000–200,000 per unit, straining tight capital budgets. Annual maintenance contracts add 8–12% of purchase cost and need on-site biomedical engineers who are scarce. Budget pressures lead 34% of hospitals to extend replacement cycles beyond manufacturer guidance, raising downtime and safety risks. Smaller community facilities fare worst because reimbursement barely covers operating cost, let alone depreciation. These realities slow refresh cycles and temper near-term demand despite clear clinical benefits.
Space constraints limit deployment of large equipment
A full cardiovascular gym needs roughly 2,500 sq ft, yet urban hospitals face escalating real-estate costs that force difficult allocation choices. Administrators often prioritise surgical suites over rehabilitation floor space, leaving programs to share crowded basements or outpatient annexes. The squeeze is acute in Asia-Pacific megacities where land premiums curb expansion of new units. Vendors now offer compact multi-function ergometers and fold-away strength stations, though higher unit prices slow uptake. Without creative space solutions, program capacity will remain capped even as patient referrals climb.
Segment Analysis
By Product Type: Innovation Anchored in Emerging Technologies
Aerobic training equipment retained 34.45% revenue in 2024, reflecting its foundational role in cardiac care. Treadmills and cycle-ergometers remain first-line interventions because extensive clinical trials prove gains in functional capacity and mortality reduction. Strength systems complement aerobic modalities, while upgraded telemetry modules link directly to electronic health records. The cardiac rehabilitation equipment market continues to reward firms that integrate diagnostics with exercise hardware.
The emerging technologies subset posts the fastest 6.27% CAGR through 2030 as VR stations and robotic exoskeletons transition from pilot programs to commercial scale. CardioVR-ReTone exemplifies advanced exoskeleton design, combining 12 degrees of freedom with immersive scenery to sustain motivation. Gamification and motion capture redefine the user experience, helping vendors secure new reimbursements and attracting institutional buyers focused on patient engagement.
Note: Segment shares of all individual segments available upon report purchase
By Portability: Home-Based Solutions Gain Momentum
Fixed installations captured 71.29% revenue in 2024 thanks to full monitoring suites, crash carts, and integrated emergency protocols required for high-risk cohorts. Facilities capitalise on economies of scale and staff competencies, reinforcing the role of fixed units within the cardiac rehabilitation equipment market.
Portable systems register a 7.23% CAGR as technology miniaturisation and secure wireless channels bring clinical oversight to living rooms. Remote programs showed equivalent outcomes to on-site care at lower travel and scheduling burden. Firms now bundle connected cycle-ergometers with tablets and blood-pressure cuffs, helping providers meet participation goals during staffing shortages.
By End User: Expansion Beyond Hospital Walls
Hospitals held 47.87% of overall revenues in 2024 because phase II programs require telemetry, crash support, and immediate physician access. Integrated cardiology teams lead early adoption of AI dashboards and robotic trainers, reinforcing hospital demand for premium hardware in the cardiac rehabilitation equipment industry.
Home settings grow at a 7.56% CAGR to 2030, reflecting payer push for value-based care and patient preference for remote options. Virtual platforms cut readmissions from 43% to 15% among high-risk patients. Insurers continue to refine billing codes that encourage technology-enabled home models.
Note: Segment shares of all individual segments available upon report purchase
By Technology Integration: Digital Health Transforms Delivery
AI engines embedded within ergometers adjust resistance and pace at each heartbeat, ensuring workloads remain in therapeutic zones. Continuous data streams support early alerts and predictive analytics that lower adverse-event likelihood.
Telerehabilitation platforms address Japan’s low 3–7% participation rate by linking outpatient sessions to cloud dashboards, bypassing the need for on-site cardiologists. National societies endorse remote programs to widen access and align with healthy-aging policies.
Geography Analysis
North America contributed 39.50% revenue in 2024. Medicare reimbursement for virtual rehabilitation encourages hybrid models combining in-clinic baseline testing with home follow-up. Digital health start-ups such as Carda Health and Movn Health supply turnkey platforms, yet participation remains lower among women and Black seniors despite proven benefit.
Europe sustains dense infrastructure, with 90.9% of countries hosting programs and adherence touching 85%, although risk-factor modification lags expectations. EU initiatives standardise outcome reporting and encourage AI integration to personalise dosing.
Asia Pacific records the swiftest 6.71% CAGR. Japan's strict reimbursement codes limit utilisation to 3-7% of eligible patients. China has opened more than 500 centres, yet only 24% of hospitals operate active programs, constrained by affordability and distance. Regional consortia now champion telerehabilitation and low-cost portable kits to bridge service gaps.
Competitive Landscape
The cardiac rehabilitation equipment market is moderately fragmented but trending toward consolidation as multinationals add rehabilitation assets to cardiovascular portfolios. Competitive advantage is moving toward software, where AI algorithms, cloud security, and analytics dashboards shape purchasing decisions.
HeartBeam integrated AccurKardia's ECG analytics to broaden its algorithm library and improve diagnostic precision. Anumana and InfoBionic.Ai link FDA-cleared ECG-AI with remote telemetry to shorten detection timelines for arrhythmias.
Digital health newcomers challenge incumbents. Recora secured USD 20 million to scale virtual programs, while ScottCare's move into Marmon Holdings injects equity for R&D and distribution. Vendors now target white-space segments such as paediatric and post-surgical applications with modular designs.
Cardiac Rehabilitation Industry Leaders
-
GE Healthcare
-
Koninklijke Philips N.V.
-
Omron Corporation
-
Core Health & Fitness, LLC
-
Technogym
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- September 2024: Pritikin ICR acquired Chanl Health to expand hybrid outpatient rehabilitation services.
- August 2024: Washington regulators cleared a 50-bed inpatient rehabilitation hospital in Vancouver featuring robotic-assisted therapy devices.
Global Cardiac Rehabilitation Market Report Scope
Cardiac rehabilitation includes supervision of the heart condition with medical aid, including proper exercises and doctor-recommended medical devices. Cardiac rehabilitation is the procedure that is carried out after getting treatment for certain conditions such as heart attack or failure, heart surgery, or bypass grafting.
The cardiac rehabilitation market is segmented by product type (treadmill, elliptical trainer, stabilization ball, rower, blood pressure monitor, heart rate monitor, and other product types) and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
The report offers the value (in USD) for the above segments.
| Aerobic Training Equipment | Treadmills |
| Upright / Recumbent Bikes | |
| Arm-Ergometers & Rowers | |
| Strength Training Equipment | Pneumatic Weight Machines |
| Resistance Bands & Training Balls | |
| Monitoring & Feedback Devices | ECG/Telemetry Systems |
| Blood-Flow & Metabolic Monitors | |
| Emerging Technologies | VR-based Rehab Stations |
| Robotics & Exoskeletons |
| Fixed (Facility-based) |
| Portable / Home-use |
| Hospitals |
| Rehabilitation Centres |
| Specialty Cardiac Clinics |
| Home Settings |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Russia | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| South Korea | |
| Australia | |
| Rest of Asia-Pacific | |
| Middle East & Africa | GCC |
| South Africa | |
| Rest of Middle East & Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Product Type (Value) | Aerobic Training Equipment | Treadmills |
| Upright / Recumbent Bikes | ||
| Arm-Ergometers & Rowers | ||
| Strength Training Equipment | Pneumatic Weight Machines | |
| Resistance Bands & Training Balls | ||
| Monitoring & Feedback Devices | ECG/Telemetry Systems | |
| Blood-Flow & Metabolic Monitors | ||
| Emerging Technologies | VR-based Rehab Stations | |
| Robotics & Exoskeletons | ||
| By Portability (Value) | Fixed (Facility-based) | |
| Portable / Home-use | ||
| By End-User (Value) | Hospitals | |
| Rehabilitation Centres | ||
| Specialty Cardiac Clinics | ||
| Home Settings | ||
| By Region | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| South Korea | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| Middle East & Africa | GCC | |
| South Africa | ||
| Rest of Middle East & Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
What is the current value of the cardiac rehabilitation equipment market?
The cardiac rehabilitation equipment market size reached USD 2.45 billion in 2025 and is projected to grow steadily to USD 3.28 billion by 2030.
Which product segment holds the largest share?
Aerobic training equipment accounted for 34.45% of 2024 revenues, reflecting its continued central role in exercise-based therapy.
Why are portable devices gaining traction?
Portable systems support home-based programs that improve access, cut travel time, and achieve comparable clinical outcomes to facility care, driving a 7.23% CAGR through 2030.
Which region is expanding the fastest?
Asia Pacific leads growth with a 6.71% CAGR as telerehabilitation and AI tools help overcome low participation rates in traditional programs.
How is artificial intelligence used in cardiac rehabilitation equipment?
In 2025, the North America accounts for the largest market share in Cardiac Rehabilitation Market.
Page last updated on: